SI1870409T1 - Spojine benzimidazola - Google Patents
Spojine benzimidazolaInfo
- Publication number
- SI1870409T1 SI1870409T1 SI200630712T SI200630712T SI1870409T1 SI 1870409 T1 SI1870409 T1 SI 1870409T1 SI 200630712 T SI200630712 T SI 200630712T SI 200630712 T SI200630712 T SI 200630712T SI 1870409 T1 SI1870409 T1 SI 1870409T1
- Authority
- SI
- Slovenia
- Prior art keywords
- benzimidazole compounds
- benzimidazole
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005117643 | 2005-04-15 | ||
| US67584805P | 2005-04-29 | 2005-04-29 | |
| EP06731998A EP1870409B1 (en) | 2005-04-15 | 2006-04-17 | Benzimidazole compounds |
| PCT/JP2006/308069 WO2006112442A1 (ja) | 2005-04-15 | 2006-04-17 | ベンズイミダゾール化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1870409T1 true SI1870409T1 (sl) | 2010-08-31 |
Family
ID=37115157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200630712T SI1870409T1 (sl) | 2005-04-15 | 2006-04-17 | Spojine benzimidazola |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20070015782A1 (sl) |
| EP (1) | EP1870409B1 (sl) |
| JP (1) | JP4949246B2 (sl) |
| KR (1) | KR101285696B1 (sl) |
| AU (1) | AU2006237974B2 (sl) |
| BR (1) | BRPI0608400B8 (sl) |
| CA (1) | CA2602610C (sl) |
| CY (1) | CY1110074T1 (sl) |
| DE (1) | DE602006014261D1 (sl) |
| DK (1) | DK1870409T3 (sl) |
| ES (1) | ES2344467T3 (sl) |
| HK (1) | HK1117826A1 (sl) |
| HR (1) | HRP20100389T1 (sl) |
| IL (1) | IL186282A (sl) |
| ME (1) | ME01855B (sl) |
| NO (1) | NO339502B1 (sl) |
| NZ (1) | NZ561920A (sl) |
| PL (1) | PL1870409T3 (sl) |
| PT (1) | PT1870409E (sl) |
| RS (1) | RS51389B (sl) |
| RU (1) | RU2409573C2 (sl) |
| SI (1) | SI1870409T1 (sl) |
| WO (1) | WO2006112442A1 (sl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070015782A1 (en) * | 2005-04-15 | 2007-01-18 | Eisai Co., Ltd. | Benzimidazole compound |
| WO2007122686A1 (ja) * | 2006-04-14 | 2007-11-01 | Eisai R & D Management Co., Ltd. | ベンズイミダゾール化合物 |
| JP2009196894A (ja) * | 2006-10-13 | 2009-09-03 | Eisai R & D Management Co Ltd | スルフィニルベンズイミダゾール化合物またはその塩の製造方法 |
| EP2065379A4 (en) * | 2006-10-13 | 2011-01-19 | Eisai R&D Man Co Ltd | BENZIMIDAZOLE HAVING INHIBITORY ACTIVITY OF GASTRIC ACID SECRETION |
| TWI460182B (zh) * | 2007-04-11 | 2014-11-11 | Daiichi Sankyo Co Ltd | 原酸酯之製造方法 |
| SI2071986T1 (sl) * | 2007-12-18 | 2012-04-30 | Nestec Sa | Sistem za pripravo napitka iz sestavin, podprt s kodiranim vloĹľkom |
| EP2588467A1 (en) | 2010-07-01 | 2013-05-08 | Amgen Inc. | Heterocyclic compounds and their use as inhibitors of pi3k activity |
| BR112015004637B1 (pt) | 2012-09-04 | 2022-04-05 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Derivados de imidazolina, seus usos e seus processos de preparação, e composição farmacêutica |
| EP2803666B1 (de) | 2013-05-17 | 2016-04-27 | Symrise AG | Cyclische Acetale und Ketale sowie deren Verwendung als Riechstoff |
| JP6377334B2 (ja) * | 2013-10-25 | 2018-08-22 | 東洋鋼鈑株式会社 | 非線形光学色素、フォトリフラクティブ材料組成物、フォトリフラクティブ基材およびホログラム記録媒体 |
| US10307748B2 (en) | 2014-12-26 | 2019-06-04 | The University Of Tokyo | Method for producing proton pump inhibitor compound having optical activity |
| US10544113B2 (en) | 2016-03-07 | 2020-01-28 | National Health Research Institute | Thiazolidinone compounds and use thereof |
| CN112457175B (zh) * | 2020-11-03 | 2022-09-02 | 山东师范大学 | 一种制备1,3-二苄氧基-2-丙酮的方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8300736D0 (sv) * | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
| DK585485A (da) | 1984-12-18 | 1986-08-08 | Utsuka Pharm Co Ltd | Tetrahydroquinolinderivat, imidazopyridinderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat med mindst en saadan forbindelse |
| JPS62277322A (ja) | 1986-02-13 | 1987-12-02 | Takeda Chem Ind Ltd | 安定化された腸溶性抗潰瘍固形組成物 |
| JPS62207271A (ja) | 1986-03-06 | 1987-09-11 | Yamanouchi Pharmaceut Co Ltd | ２−ピリジルメチルチオ基または２−ピリジルメチルスルフイニル基で置換された縮合環化合物 |
| GB2189699A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
| JPH0643426B2 (ja) | 1986-07-25 | 1994-06-08 | 東京田辺製薬株式会社 | イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 |
| US5026560A (en) | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
| JPH0222273A (ja) * | 1987-07-21 | 1990-01-25 | Yoshitomi Pharmaceut Ind Ltd | ピリジン化合物およびその医薬用途 |
| JPH0633261B2 (ja) | 1988-01-22 | 1994-05-02 | 東京田辺製薬株式会社 | 新規なイミダゾ［４，５−ｂピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 |
| SE9002206D0 (sv) * | 1990-06-20 | 1990-06-20 | Haessle Ab | New compounds |
| WO1991019712A1 (en) * | 1990-06-20 | 1991-12-26 | Aktiebolaget Astra | Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
| JP2820829B2 (ja) | 1991-03-07 | 1998-11-05 | 武田薬品工業株式会社 | 有核散剤およびその製造方法 |
| JPH05117268A (ja) * | 1991-10-22 | 1993-05-14 | Yoshitomi Pharmaceut Ind Ltd | ピリジン化合物 |
| JPH05177268A (ja) | 1992-01-09 | 1993-07-20 | Amada Co Ltd | 縦型パンチプレス |
| AU746084B2 (en) | 1998-04-17 | 2002-04-11 | Taisho Pharmaceutical Co., Ltd. | Multiple-unit sustained release tablets |
| NZ510180A (en) | 1998-08-10 | 2002-11-26 | Univ California | Prodrugs of the pyridyl-methylsulphonyl-benzimidazole type proton pump inhibitors |
| TW404832B (en) | 1999-01-27 | 2000-09-11 | Nang Kuang Pharmaceutical Co L | The oral medicine with good stability cotaining the omeprazole or the analogues |
| US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
| WO2000050037A1 (en) | 1999-02-26 | 2000-08-31 | Nitromed, Inc. | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use |
| ES2168043B1 (es) | 1999-09-13 | 2003-04-01 | Esteve Labor Dr | Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido. |
| US20020064555A1 (en) | 2000-09-29 | 2002-05-30 | Dan Cullen | Proton pump inhibitor formulation |
| JP4331930B2 (ja) | 2001-10-17 | 2009-09-16 | 武田薬品工業株式会社 | 酸に不安定な薬物の高含量顆粒 |
| EP2258351B1 (en) | 2001-10-17 | 2013-06-19 | Takeda Pharmaceutical Company Limited | Granules containing lansoprazole in large amount |
| JP2003137771A (ja) | 2001-10-30 | 2003-05-14 | Nichiko Pharmaceutical Co Ltd | 難溶性薬物用医薬製剤 |
| SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
| MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
| US20040166162A1 (en) | 2003-01-24 | 2004-08-26 | Robert Niecestro | Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
| US8449911B2 (en) | 2003-03-12 | 2013-05-28 | Takeda Pharmaceutical Company Limited | Drug composition having active ingredient adhered at high concentration to spherical core |
| WO2005011637A1 (ja) | 2003-08-04 | 2005-02-10 | Eisai Co., Ltd. | 用時分散型製剤 |
| US20070015782A1 (en) * | 2005-04-15 | 2007-01-18 | Eisai Co., Ltd. | Benzimidazole compound |
-
2006
- 2006-04-14 US US11/403,815 patent/US20070015782A1/en not_active Abandoned
- 2006-04-17 CA CA2602610A patent/CA2602610C/en active Active
- 2006-04-17 DK DK06731998.8T patent/DK1870409T3/da active
- 2006-04-17 RU RU2007138053/04A patent/RU2409573C2/ru active
- 2006-04-17 RS RSP-2010/0346A patent/RS51389B/en unknown
- 2006-04-17 EP EP06731998A patent/EP1870409B1/en active Active
- 2006-04-17 KR KR1020077023561A patent/KR101285696B1/ko active IP Right Grant
- 2006-04-17 ES ES06731998T patent/ES2344467T3/es active Active
- 2006-04-17 WO PCT/JP2006/308069 patent/WO2006112442A1/ja active Application Filing
- 2006-04-17 AU AU2006237974A patent/AU2006237974B2/en active Active
- 2006-04-17 NZ NZ561920A patent/NZ561920A/en not_active IP Right Cessation
- 2006-04-17 JP JP2007528143A patent/JP4949246B2/ja active Active
- 2006-04-17 DE DE602006014261T patent/DE602006014261D1/de active Active
- 2006-04-17 ME MEP-2010-346A patent/ME01855B/me unknown
- 2006-04-17 SI SI200630712T patent/SI1870409T1/sl unknown
- 2006-04-17 BR BRPI0608400A patent/BRPI0608400B8/pt active IP Right Grant
- 2006-04-17 PL PL06731998T patent/PL1870409T3/pl unknown
- 2006-04-17 PT PT06731998T patent/PT1870409E/pt unknown
- 2006-09-14 US US11/520,838 patent/US7425634B2/en active Active
-
2007
- 2007-09-25 IL IL186282A patent/IL186282A/en active IP Right Grant
- 2007-11-15 NO NO20075904A patent/NO339502B1/no not_active IP Right Cessation
-
2008
- 2008-07-17 HK HK08107942.6A patent/HK1117826A1/xx not_active IP Right Cessation
- 2008-08-11 US US12/189,590 patent/US8124780B2/en not_active Expired - Fee Related
-
2010
- 2010-06-11 CY CY20101100543T patent/CY1110074T1/el unknown
- 2010-07-15 HR HR20100389T patent/HRP20100389T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0503962D0 (en) | Compounds | |
| GB0502418D0 (en) | Compounds | |
| GB0502316D0 (en) | Compounds | |
| SI1870409T1 (sl) | Spojine benzimidazola | |
| EP1961741A4 (en) | M-CARBAZOLYLPHENYL COMPOUNDS | |
| IL189897A0 (en) | Benzimidazole thiophene compounds | |
| EP2088861A4 (en) | BENZIMIDAZOLE COMPOUNDS | |
| GB0502299D0 (en) | Compounds | |
| GB0502310D0 (en) | Compounds | |
| AP2007004220A0 (en) | Motilide compounds | |
| GB0505084D0 (en) | Compounds | |
| GB0503961D0 (en) | Compounds | |
| EP1907385A4 (en) | LINKS | |
| GB0506467D0 (en) | Compounds | |
| GB0505086D0 (en) | Compounds | |
| GB0505509D0 (en) | Compounds | |
| GB0505735D0 (en) | Compounds | |
| ZA200708803B (en) | Benzimidazole compound | |
| GB0501985D0 (en) | Compounds | |
| IL223313A (en) | Benzimidazoles | |
| EP1867650A4 (en) | HYDROXYMETHYLBORVERBINDUNGEN | |
| GB0505085D0 (en) | Compounds | |
| GB0501984D0 (en) | Compounds | |
| GB0503145D0 (en) | Compounds | |
| GB0505214D0 (en) | Compounds |